The complicated world of compounded weight-loss drugs
On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...
Medscape6 天
Compounded GLP-1s: Navigating the Telemedicine Landscape and Ensuring Patient Safety
Are compounded GLP-1s safe? Dr Ro breaks down the risks, FDA concerns, and telemedicine's role in prescribing these meds — ...
What is compounded semaglutide? All you need to know about the weight loss drugs Hims ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
WCPO Cincinnati56 分钟
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
STAT4 天
Dozens of attorneys general urge FDA to crack down on counterfeit obesity drugs
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Indiatimes13 天
What is compounded semaglutide? All you need to know about the weight loss drugs Hims ...
Now, as all of it might sound slightly confusing, let’s break it down for you. Side effects of compounded drugs can include potential contamination due to poor compounding practices, incorrect ...
Healio4 天
FDA removes semaglutide from drug shortage list
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...
WTKR2 天
FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...